Postprandial Endotoxemia Predicts Repeat Heart Events — Mediterranean Diet Cuts the Risk
After meals, bacterial toxins leaking into the bloodstream raise the odds of a second heart attack. The Mediterranean diet outperforms low-fat diets in blunting this threat.
Summary
A seven-year clinical trial of over 1,000 coronary heart disease patients found that people with higher spikes in blood-borne bacterial toxins (LPS) after eating faced a 42% greater risk of suffering another major cardiovascular event. The Mediterranean diet reduced these toxic spikes more effectively than a standard low-fat diet, partly by reshaping the gut microbiome toward a healthier profile. This research suggests that measuring postprandial endotoxemia — essentially how much bacterial toxin leaks into circulation after a meal — could become a practical tool for personalizing secondary cardiovascular prevention, and that choosing the Mediterranean diet over a low-fat approach may be a meaningful protective strategy for heart disease patients.
Detailed Summary
Every meal triggers subtle changes in the gut that can ripple outward into the bloodstream. For people who have already suffered a cardiac event, one of those changes — a surge in bacterial toxins called lipopolysaccharide (LPS) after eating — may be quietly pushing them toward a second one. This finding, drawn from a landmark Spanish clinical trial, adds a new dimension to how clinicians might monitor and manage cardiovascular risk.
The CORDIOPREV trial enrolled 1,002 patients with established coronary heart disease and randomly assigned them to follow either a Mediterranean diet or a low-fat diet for seven years. At baseline and again at three years, participants consumed a standardized mixed meal and had their blood LPS levels measured before and after eating. Gut microbiota were also profiled using 16S metagenomics.
The core result was striking: patients in the highest group for postprandial LPS increase had a 42% greater hazard of suffering a major adverse cardiovascular event (MACE) over the seven-year follow-up compared to those with lower post-meal endotoxemia. The association held after adjustment via Cox regression analysis. Among patients with moderate LPS increases, those on the low-fat diet carried a 45% higher MACE risk than those on the Mediterranean diet.
Both diets reduced absolute LPS concentrations and encouraged a gut microbiome composition linked to lower postprandial endotoxin release. However, the Mediterranean diet demonstrated a consistently stronger protective effect, suggesting that its specific composition — rich in polyphenols, fiber, and healthy fats — may better reinforce gut barrier integrity and microbiome balance.
For clinicians managing secondary cardiovascular prevention, these findings make a compelling case for incorporating postprandial LPS measurement into risk stratification. They also reinforce Mediterranean diet prescription over generic low-fat dietary advice for heart disease patients. Limitations include the observational nature of the endotoxemia-MACE association and reliance on the abstract only.
Key Findings
- High postprandial LPS spikes associated with 42% increased MACE risk over 7 years in CHD patients.
- Mediterranean diet reduced postprandial endotoxemia more effectively than a low-fat diet.
- Moderate LPS responders on a low-fat diet had 45% higher MACE risk than those on the Mediterranean diet.
- Both diets shifted gut microbiome toward profiles associated with lower post-meal LPS release.
- Postprandial endotoxemia measurement proposed as a personalized secondary prevention biomarker.
Methodology
The CORDIOPREV trial (NCT00924937) randomized 1,002 coronary heart disease patients to a Mediterranean or low-fat diet for 7 years. Postprandial LPS was measured via Limulus Amebocyte Lysate colorimetric assay following a standardized mixed meal at baseline and 3-year follow-up. MACE associations were assessed using Cox proportional hazards regression; gut microbiota were characterized by 16S metagenomics.
Study Limitations
The association between postprandial endotoxemia and MACE is observational within a randomized trial, so causality cannot be definitively confirmed. The study population was composed exclusively of existing coronary heart disease patients in Spain, which may limit generalizability to other populations. This summary is based on the abstract only, as the full text was not available.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: